Page last updated: 2024-11-05

linalyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Linalyl acetate is a naturally occurring ester found in many essential oils, particularly lavender and bergamot. It is a colorless liquid with a sweet, floral aroma. It is commonly used in perfumery and aromatherapy. Linalyl acetate is synthesized by the esterification of linalool with acetic acid. It is known for its relaxing and calming effects. Research suggests that it may have anxiolytic and sedative properties. Linalyl acetate is also being studied for its potential antimicrobial and insecticidal activities. The compound is of interest for its potential applications in various fields, including cosmetics, pharmaceuticals, and agriculture.'

linalyl acetate: structure in first source; RN refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

linalyl acetate : A racemate comprising equimolar amounts of (R)- and (S)-linalyl acetate. It forms a principal component of the essential oils from bergamot and lavender. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

3,7-dimethylocta-1,6-dien-3-yl acetate : A monoterpenoid that is the acetate ester of linalool. It forms a principal component of the essential oils from bergamot and lavender. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8294
CHEMBL ID502773
CHEBI ID78333
SCHEMBL ID58028
MeSH IDM0201043

Synonyms (96)

Synonym
AC-20000
bergamiol
1, 3,7-dimethyl-, acetate
linalol acetate
linalool acetate
3,6-octadien-3-ol acetate
nsc2138
acetic acid linalool ester
wln: 1y&u3y1u1ov1
bergamol
3,6-octadien-3-yl acetate
nsc-2138
licareol acetate
lynalyl acetate
1,5-dimethyl-1-vinylhex-4-en-1-yl acetate
(1)-1,5-dimethyl-1-vinylhex-4-enyl acetate
linalyl acetate (natural)
dehydrolinalool, acetate
3,7-dimethyl-1,6-ctadien-3-ol acetate
ex bois de rose (synthetic)
3,7-dimethyl-1,6-octadien-3-ol acetate
hsdb 644
einecs 204-116-4
einecs 254-806-4
nsc 2138
3,7-dimethyl-1,6-octadien-3-yl acetate
ai3-00941
fema no. 2636
1,6-octadien-3-ol, 3,7-dimethyl-, acetate
linalyl acetate
115-95-7
3,7-dimethyl-1,6-octadien-3-yl acetate, 97%
linalyl acetate, natural, >=80%
linalyl acetate, >=97%, fcc, fg
NCGC00164001-01
3,7-dimethylocta-1,6-dien-3-yl acetate
linalyl acetate synthetic
aetic acid linalool ester
chebi:78333 ,
CHEMBL502773
L0049
NCGC00164001-02
linalyl acetater
cas-115-95-7
tox21_303134
NCGC00257047-01
dtxcid006946
dtxsid7026946 ,
NCGC00258858-01
tox21_201306
(1,5-dimethyl-1-vinyl-hex-4-enyl) acetate
ec 204-116-4
unii-5k47ssq51g
5k47ssq51g ,
1,6-octadien-3-ol, 3,7-dimethyl-, 3-acetate
FT-0627862
AKOS015901735
linalyl acetate, (+/-)-
linalyl acetate [mi]
linalyl acetate [fhfi]
linaloyl acetate, (+/-)-
linalool acetate, dl-
linalyl acetate [usp-rs]
linalyl acetate [fcc]
linalyl acetate [hsdb]
linalyl acetate [inci]
SCHEMBL58028
3,7-dimethyl-1,6octadien-3-yl acetate
phanteine
1,5-dimethyl-1-vinyl-4-hexenyl acetate
linaloyl acetate
(.+/-.)-linalyl acetate
W-108587
mfcd00008907
linalyl acetate, analytical standard
acetic acid-linalyl ester
3,7-dimethyl-acetate(3r)-1,6-octadien-3-ol
1,6-octadien-3-ol, 3, 7-dimethyl-, acetate
3,7-dimethyl-3-acetate(3r)-1,6-octadien-3-ol
fema 2636
(-)-s-linalyl acetate
Q188314
(+/-)-linalyl acetate
CS-W010587
acetic acid-linalyl ester 1000 microg/ml in acetonitrile
BS-49383
HY-N6948
A893739
E80781
unii: 5k47ssq51g
flavor and extract manufacturers' association no. 2636
linalyl acetate (usp-rs)
1,5-dimethyl-1-vinylhex-4-enyl acetate
salvia desoleana atzei & picci essential oil.
EN300-7444436
Z1255415454

Research Excerpts

Overview

Linalyl acetate is a fragrance chemical that is prone to autoxidation.

ExcerptReferenceRelevance
"Linalyl acetate is a fragrance chemical that is prone to autoxidation. "( Air-oxidized linalyl acetate - an emerging fragrance allergen?
Berglund, V; Bråred Christensson, J; Hagvall, L, 2015
)
2.23

Effects

ExcerptReferenceRelevance
"Linalyl acetate (LA) has been reported to have therapeutic effects in ischemic stroke by modulating intracellular Ca2+ concentration and having anti-oxidative properties."( Linalyl acetate prevents hypertension-related ischemic injury.
Hsieh, YS; Kwon, S; Lee, HS; Seol, GH, 2018
)
2.64

Toxicity

ExcerptReferenceRelevance
" Since EO can be applied by inhalation, dermal application and oral administration, we used several mammalian cell lines to assess safe bioactive doses."( Myrtus communis L. as source of a bioactive and safe essential oil.
Bighelli, A; Bouzabata, A; Cabral, C; Casanova, J; Cavaleiro, C; Cruz, MT; Gonçalves, MJ; Salgueiro, L; Tomi, F, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
monoterpenoidAny terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency30.63790.000714.592883.7951AID1259369
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency10.00000.000214.376460.0339AID588532
estrogen nuclear receptor alphaHomo sapiens (human)Potency19.49860.000229.305416,493.5996AID743069
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency4.364119.739145.978464.9432AID1159509
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency54.48270.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency54.48270.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID1090214Antifungal activity against Aspergillus flavus assessed as inhibition of mycelial growth in dextrose sabouraud broth and Czapek agar at 0.5 mg/ml at 28 +/- 1 degC for 72 hr by dilution technique2005Journal of agricultural and food chemistry, Jun-01, Volume: 53, Issue:11
Chemical composition and antifungal activity of essential oil of Chrysactinia mexicana gray.
AID1101968Antifungal activity against Fusarium oxysporum f. sp. dianthi after 4 days2002Journal of agricultural and food chemistry, Nov-06, Volume: 50, Issue:23
Composition and antifungal activity on soil-borne pathogens of the essential oil of Salvia sclarea from Greece.
AID338299Acaricidal activity against Psoroptes cuniculi at 0.125% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1090219Antifungal activity against Aspergillus flavus assessed as inhibition of mycelial growth in dextrose sabouraud broth and Czapek agar at 0.1 mg/ml at 28 +/- 1 degC for 72 hr by dilution technique2005Journal of agricultural and food chemistry, Jun-01, Volume: 53, Issue:11
Chemical composition and antifungal activity of essential oil of Chrysactinia mexicana gray.
AID659296Antimycoplasmal activity against Mycoplasma fermentans Pg18 after 24 to 48 hrs by broth microdilution method2012European journal of medicinal chemistry, Jun, Volume: 52In vitro antimycoplasmal activity of Citrus bergamia essential oil and its major components.
AID1090216Antifungal activity against Aspergillus flavus assessed as inhibition of mycelial growth in dextrose sabouraud broth and Czapek agar at 0.3 mg/ml at 28 +/- 1 degC for 72 hr by dilution technique2005Journal of agricultural and food chemistry, Jun-01, Volume: 53, Issue:11
Chemical composition and antifungal activity of essential oil of Chrysactinia mexicana gray.
AID659295Antimycoplasmal activity against Mycoplasma hominis PG21 after 24 to 48 hrs by broth microdilution method2012European journal of medicinal chemistry, Jun, Volume: 52In vitro antimycoplasmal activity of Citrus bergamia essential oil and its major components.
AID1090217Antifungal activity against Aspergillus flavus assessed as inhibition of mycelial growth in dextrose sabouraud broth and Czapek agar at 0.2 mg/ml at 28 +/- 1 degC for 72 hr by dilution technique2005Journal of agricultural and food chemistry, Jun-01, Volume: 53, Issue:11
Chemical composition and antifungal activity of essential oil of Chrysactinia mexicana gray.
AID338302Acaricidal activity against Psoroptes cuniculi at 1 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1101970Antifungal activity against Sclerotinia sclerotiorum after 4 days2002Journal of agricultural and food chemistry, Nov-06, Volume: 50, Issue:23
Composition and antifungal activity on soil-borne pathogens of the essential oil of Salvia sclarea from Greece.
AID338300Acaricidal activity against Psoroptes cuniculi at 6 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID659297Antimycoplasmal activity against Mycoplasma pneumoniae K7 after 3 to 5 days by broth microdilution method2012European journal of medicinal chemistry, Jun, Volume: 52In vitro antimycoplasmal activity of Citrus bergamia essential oil and its major components.
AID1101969Antifungal activity against Sclerotium cepivorum after 4 days2002Journal of agricultural and food chemistry, Nov-06, Volume: 50, Issue:23
Composition and antifungal activity on soil-borne pathogens of the essential oil of Salvia sclarea from Greece.
AID338297Acaricidal activity against Psoroptes cuniculi at 1% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1090215Antifungal activity against Aspergillus flavus assessed as inhibition of mycelial growth in dextrose sabouraud broth and Czapek agar at 0.4 mg/ml at 28 +/- 1 degC for 72 hr by dilution technique2005Journal of agricultural and food chemistry, Jun-01, Volume: 53, Issue:11
Chemical composition and antifungal activity of essential oil of Chrysactinia mexicana gray.
AID338298Acaricidal activity against Psoroptes cuniculi at 0.25% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID338301Acaricidal activity against Psoroptes cuniculi at 3 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1090218Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in dextrose sabouraud broth and Czapek agar at 28 +/- 1 degC for 72 hr by dilution technique2005Journal of agricultural and food chemistry, Jun-01, Volume: 53, Issue:11
Chemical composition and antifungal activity of essential oil of Chrysactinia mexicana gray.
AID1090213Antifungal activity against Aspergillus flavus assessed as inhibition of mycelial growth in dextrose sabouraud broth and Czapek agar at 0.6 mg/ml at 28 +/- 1 degC for 72 hr by dilution technique2005Journal of agricultural and food chemistry, Jun-01, Volume: 53, Issue:11
Chemical composition and antifungal activity of essential oil of Chrysactinia mexicana gray.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (89)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (5.62)18.2507
2000's22 (24.72)29.6817
2010's49 (55.06)24.3611
2020's13 (14.61)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 63.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index63.48 (24.57)
Research Supply Index4.55 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index103.92 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (63.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (2.17%)5.53%
Reviews3 (3.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other87 (94.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]